bioRxivCancer BiologyPreprint
MYC shapes ER-mitochondria calcium transfer by directly targeting ITPR1: implications for MYC-induced safeguard mechanisms and cancer
Xingjie MaiD, Athanasios TsalikisiD, Mathieu VernieriD, Kexin ZhuiD, Jéhanne El Hassani, Dorian V. ZiegleriD, Anda HunaiD, Claire Coquet, Gwladys RevêchoniD, Céline Margand, Flavie Bénard, Joanna Czarnecka‐HerokiD, Isabelle Iacono, Catherine Koering, Valéry AttignoniD, Marjorie Carrère, Florence Jollivet, Bertrand MollereauiD, Christophe VanbelleiD, Olivier GandrilloniD, Benoît DumontiD, Céline Delloye‐BourgeoisiD, Héctor Hernández‐VargasiD, Laura BroutieriD, Nadine MartiniD, David BernardiD
Abstract
The MYC and NMYC transcription factors (TFs) play a key role in cell proliferation and are overexpressed in most cancer cells. However, in normal cells their overexpression triggers safeguard mechanisms promoting cell death and cellular senescence, which are bypassed in cancer cells. The mechanisms of action of this TF family are only partially understood. Here, we reveal that in normal cells MYC binds to the Inositol 1,4,5-Trisphosphate Receptor type 1 (ITPR1) gene and upregulates its expression, triggering an ER-mitochondria calcium (Ca2+) transfer, which is involved in MYC-induced cell death and senescence. Supporting a tumor suppressive role of MYC/ITPR1 axis, ITPR1 expression is generally decreased in cancer and reactivation of this pathway induces cancer cell death. Nevertheless, some cancer cells, generally expressing high levels of MYCN and/or MYC, also express high level of ITPR1, which correlates with high expression of BCL2, encoding an inhibitor of ITPR1. Strikingly, in high-risk MYCN-amplified neuroblastoma, ITPR1 expression is controlled by NMYC and its level correlates with worse patient survival. In these cells, blocking the interaction between BCL2 and ITPR1 induces mitochondrial Ca2+ accumulation and cell death, and decreases tumor size. Collectively these data highlight a new function of MYC factors by controlling Ca2+ signaling, which could constitute an unsuspected vulnerability for some cancer cells, including high-risk MYCN-amplified neuroblastoma cells.
- organism: human
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibiting mitochondrial translation overcomes multidrug resistance in MYC-driven neuroblastoma via OMA1-mediated integrated stress response
K. Borankova, M. Krchniakova, … J. Skoda·bioRxiv·Feb 24, 2023
- Inhibition of OCT4 Binding at the MYCN Locus Induces Neuroblastoma Cell Death Accompanied by Downregulation of Transcripts with High-Open Reading Frame Dominance
K. Nakatani, H. Kogashi, … Y. Suenaga·bioRxiv·Jun 8, 2023
- MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cells
S. Zanotti, S. Vanhauwaert, … F. Speleman·bioRxiv·Jan 22, 2021
- REDUCED ER-MITOCHONDRIA CONNECTIVITY PROMOTES NEUROBLASTOMA MULTIDRUG RESISTANCE
J. Coku, D. M. Booth, … M. D. Hogarty·bioRxiv·Mar 1, 2021
- MYCN inhibits TrkC-mediated differentiation in neuroblastoma cells via disruption of the PKA signalling pathway
Stephanie Maher, Andrew Roe, … Melinda Halász·Cell Death DiscoveryPeer-reviewed·Mar 25, 2026
- TRPML1 signaling at lysosomes-mitochondria nexus drives triple-negative breast cancer mitophagy, metabolic reprogramming and chemoresistance
Alia Kazim Rizvi Syeda, Shekoufeh Almasi, … Yassine El Hiani·bioRxiv·Sep 11, 2025